openPR Logo
Press release

Enable Injections Names Jeannie Joughin, Ph.D. Executive Vice President and Chief Commercial Officer

01-10-2018 08:53 AM CET | Health & Medicine

Press release from: KOGS Communication

/ PR Agency: KOGS Communication LLC
Dr. Jeannie Joughin named Enable Injections’ Executive Vice President and Chief Commercial Officer

Dr. Jeannie Joughin named Enable Injections’ Executive Vice President and Chief Commercial Officer

CINCINNATI, OH—January 9, 2018—Enable Injections, Inc., developer of the advanced enFuse™ large-volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has named Dr. Jeannette “Jeannie” Joughin Executive Vice President and Chief Commercial Officer.

A global pharmaceutical executive and long-time champion of a patient-focused approach to treatment, Dr. Joughin joined the company as Vice President of Corporate Development in 2015. In her new role she will support the CEO and Board with investment strategy and remains responsible for business development, strategic pharma partnerships, alliance management, as well as aiding in selection and prioritization of Enable Injections’ global portfolio.

“Jeannie has exceptional experience and a proven track record of developing mutually-beneficial partnerships with pharmaceutical companies who share our passion for radically improving the patient infusion experience,” said Michael D. Hooven, Enable Injections’ President and CEO. “Today we are recognizing her leadership in helping to drive the next phase of growth for Enable Injections.”

Prior to joining Enable Injections, Dr. Joughin was Vice President, Business Development at drug maker CSL Behring, with global responsibility. . The Australian native also served as Marketing Manager at Mayne Pharma, as General Manager of Medimark International, and held clinical and commercial roles at Bristol-Myers Squibb.

# # # #

About Enable Injections, Inc.

Founded by medical device industry veterans, Cincinnati, OH-based Enable Injections develops and manufactures wearable devices that allow easy, comfortable patient self-administration of large volume/high viscosity drugs in doses from 4 ml to 50 ml. The Enable body-worn enFuse™ drug delivery platform utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions. Enable’s devices are available for pharmaceutical and biotechnology industry investigational use. For more information please visit www.enableinjections.com and follow us on www.twitter.com/EnableInjection.

2863  E. Sharon Rd.
Cincinnati OH 45241

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Enable Injections Names Jeannie Joughin, Ph.D. Executive Vice President and Chief Commercial Officer here

News-ID: 892432 • Views: 1867

More Releases for Enable

How 5G and wireless technology would enable the software market?
The global Automotive Software Market size is projected to reach USD 37.0 billion by 2025 from USD 16.9 billion in 2020, at a CAGR of 16.9%. The growth of the market is driven by upcoming safety regulations, increase in demand for vehicle management and fuel-efficient vehicles. Increasing focus on active safety systems and car assessment programs would drive the demand for ECUs in modern vehicles. Increasing number of ECUs will drive
New radar systems enable quick integration
InnoSenT minimises development costs for security technology manufacturers with the Smart Tracker. Donnersdorf, 08/02/2019. InnoSenT GmbH has launched new products on the market. The iSYS-5011 and iSYS 5021 radar systems facilitate use of radar technology by boasting a special tracking function and are perfectly suited to meet the requirements of the security industry. They are joining the successful product family of the iSYS-5010 and 5020, designed for the reliable surveillance of
New radar systems enable quick integration
InnoSenT minimises development costs for security technology manufacturers with the Smart Tracker. Donnersdorf, 08/02/2019. InnoSenT GmbH has launched new products on the market. The iSYS-5011 and iSYS 5021 radar systems facilitate use of radar technology by boasting a special tracking function and are perfectly suited to meet the requirements of the security industry. They are joining the successful product family of the iSYS-5010 and 5020, designed for the reliable surveillance of
Menufy Partners with DoorDash to Enable Food Delivery for Restaurants
Menufy, an online and mobile food ordering provider, announced a strategic partnership with DoorDash to launch food delivery to restaurant customers in over 1,000 cities in the United States. DoorDash's last-mile logistics solution empowers Menufy's partner restaurants to grow their off-premise ordering business with on-demand delivery, analytics, and more efficient workflows. The logistics integration with DoorDash enables Menufy customers to order delivery online and to continue paying with any major credit
Gas Analyzer, Sensor and Detector Market Enable Lustrous Growth 2025
Gas Analyzer, Sensor and Detector Market: Snapshot Gas analyzers, sensors, and detectors have become a key part of several industries in recent years due to their effective contribution in averting mishaps related to gas leakage. The global gas analyzers, sensors, and detectors market is thus likely to grow at a steady rate in the coming years due to the rapid growth of the industrial sector across the world. Gas leakages can
Automated Dispensing Machines Enable Cost-Effective Services
London, UK, October 15, 2011 -- TechNavio, a market research leader in the area of Healthcare, recently published its in-depth report on the Automated Dispensing Machine Market in Japan 2010–2014. The report discusses significant trends in the Automated Dispending Machines market for the Institutions and Retail Chains sectors. TechNavio’s report highlights that the rise in automation in the Japanese Pharmacy industry is one of the major drivers for growth of the